Leading Provider of Point of Care diagnostic devices and analytical instruments for the life science industry.
To company website
At a glance
Reference market: Point of Care diagnostics
Vertical: Life Science & Diagnostics
FTEs: ~200
Acquisition year: 2023
Head office: Germany
Positive impact to society
Diagnostic testing shifting closer to patients providing faster, better outcomes
Investment rationale
- Operates in an attractive niche market with sustainable long-term growth driven by megatrend shifting testing closer to patients and Point-of-Care
- Create a strategically critical supplier of design, development and manufacturing services to the Point-of-Care and Life Sciences industries
